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Atrial Fibril lation in Eight New World Camelids
R. Bozorgmanesh, K.G. Magdesian, K.E. Estell, J.A. Stern, E.A. Swain, and L.G. Griffiths
Background: There is limited information on the incidence of clinical signs, concurrent illness and treatment options for
atrial fibrillation (AF) in New World Camelids (NWC).
Objective: Describe clinical signs and outcome of AF in NWC.
Animals: Eight New World Camelids admitted with AF.
Methods: A retrospective observational study of camelids diagnosed with AF based on characteristic findings on electro-
cardiogram (ECG).
Results: All animals had an irregularly irregular heart rhythm detected on physical examination and 4 cases had obtunded
mentation on admission. Three camelids were diagnosed with AF secondary to oleander intoxication, 3 animals had underly-
ing cardiovascular disease, 1 was diagnosed with lone AF and 1 had AF diagnosed on examination for a urethral obstruc-
tion. Five of eight animals survived to discharge and nonsurvivors consisted of animals which died or were euthanized as a
result of cardiovascular disease (2/8) or extra-cardiac disease unrelated to the AF (1/8).
Conclusions and Clinical Importance: Atrial fibrillation occurs in NWC in association with cardiovascular disease,
extra-cardiac disease or as lone AF. Amiodarone and transthoracic cardioversion were attempted in one llama with lone AF,
but were unsuccessful. Atrial fibrillation was recorded in 0.1% of admissions.
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Atrial fibrillation is the most common atrial arrhyth-mia in domestic animal species. Atrial fibrillation is
usually associated with underlying cardiac disease in
dogs and cats1 and with gastrointestinal disorders in
cattle, but can be associated with no underlying cause,
termed “lone” AF.2
The incidence of arrhythmias in llamas has been
reported to be 0.78–1.2%, as documented in 2 retro-
spective studies evaluating ECGs from 2,167 and 663
llamas, respectively.3,4 Reported rhythm abnormalities
included atrial premature contractions, AF, sinus
arrhythmia, sinus bradycardia, sinus tachycardia, ven-
tricular premature contractions, ventricular tachycardia,
abnormal cardiac conduction (unspecified), and second-
degree atrio-ventricular (AV) block. Only one of the
animals in each of those reports had atrial fibrillation.
Similar to horses, there is clinical evidence that some
healthy camelids can demonstrate second-degree AV
block at rest.4
The clinical features, treatment, and prognosis of AF
have not been well described in New World Camelids.
The objectives of this retrospective study were to
describe the clinical features of AF in camelids, includ-
ing the incidence in a referral hospital population.
Medical records for camelids presented to the
William R. Pritchard Veterinary Medical Teaching
Hospital, University of California, Davis over a 28-year
period (1986–2014) were reviewed. Inclusion criteria
were animals with AF diagnosed by ECG analysis. The
ECG recordings were obtained using a base-apex sys-
tem as used in horses. Data collected included signal-
ment, historical complaint, physical examination
(including heart rate) and clinicopathologic findings,
concurrent illness, treatment, duration of hospitaliza-
tion, and outcome.
Eight animals met the criteria for entry into the
study: 3 alpacas and 5 llamas. This represented 0.5% of
hospital visits of camelids during this same time period.
The median age was 10 years (range, 2–11 years). The
age of 1 llama was not recorded. Five camelids were
female, 2 were intact males and 1 was a castrated male.
Presenting complaints included inappetance (4/8),
lethargy (5/8), exercise intolerance (2/8), colic (2/8), res-
piratory distress (1/8), and recumbency (1/8). One llama
was presented for inability to urinate, and 1 llama was
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hospitalized with her cria and developed AF during
hospitalization, which was noted on a routine daily
examination without overt clinical signs.
The most common clinical signs were an irregularly
irregular heart rhythm noted on auscultation (8/8),
obtundation (4/8), heart murmur (2/8), and increased
bronchovesicular sounds (3/8). Tachycardia (>110 bpm)
was only noted in one llama.
A complete blood count (CBC) and serum biochemi-
cal profile were available for all 8 cases. The most com-
mon CBC and serum biochemical abnormalities are
reported in Table 1. Additional minor abnormalities
were recorded in individual cases associated with their
underlying condition.
Three animals were treated for oleander toxicity (two
confirmed with positive serum liquid chromatography-
mass spectrometry, one case was suspected) and 3 ani-
mals had underlying cardiovascular disease (one with a
VSD, one with suspected atrial septal defect (ASD;
diagnosed by echocardiography but not easily delin-
eated), and one with congestive heart failure (CHF).
One animal had a urethral obstruction and one was
diagnosed with lone AF.
Diagnosis in all 8 cases was based on ECG findings
consistent with AF. These findings included absence of
P waves, presence of f waves (oscillation of the base-
line), irregularly irregular R–R intervals, and normal to
narrow QRS complexes of varied amplitude. Echocar-
diography was performed on 4 animals. Three of the 4
camelids had underlying structural cardiac disease (one
with atrial enlargement and suspected ASD, one with
VSD, and one with CHF). One animal had no echocar-
diographic abnormalities and was diagnosed with lone
AF.
The most common therapies included intravenous
administration of isotonic fluids (4/8), partial parenteral
nutrition (2/8), antimicrobials (2/8), and intracompart-
mental administration of charcoal for oleander toxicity
(2/8). Two animals were treated for heart failure and
associated pulmonary edema with furosemide and one
of these was also treated by oral administration of
digoxin. Cardioversion was attempted in the single
llama with lone AF using amiodarone (7 mg/kg IV,
diluted and administered over 30 minutes; repeated at
3 mg/kg the following day). This was unsuccessful and
was followed by transthoracic biphasic defibrillation up
to 200 J under general inhalational anesthesia. No
adverse effects of these treatments were noted in this
animal, although he did not convert to sinus rhythm.
Duration of hospitalization ranged from 0 to 28 days,
and 6/8 of cases were discharged within a week of
admission. Three animals did not survive. One animal
was euthanized because of complications associated
with CHF, 1 animal died from oleander intoxication,
and 1 animal was euthanized after discharge because of
urethral necrosis and fibrosis with stricture formation
after urethral obstruction.
Of the five surviving camelids, one animal converted
to sinus rhythm with resolution of the underlying condi-
tion (oleander intoxication). Four animals were dis-
charged with persistent AF. These included one camelid
each with ASD, VSD, oleander intoxication, and lone
atrial fibrillation. The 6-year old llama with lone atrial
fibrillation was reported to be doing well approximately
6 months after discharge.
Atrial Fibrillation was rarely detected in New World
Camelids in this hospital population (0.1%). This is
similar to the reported incidence of only 1 case in a
population of 2,167 (0.05%) llamas obtained from the
Veterinary Medical Database at Purdue University from
participating universities from 1986–1993.3 This might
be because AF is rare in these species, or that it is inter-
mittent and self-resolving; or it might be more common
in the general population than reflected in these studies
if the animals are subclinical and the dysrhythmia goes
undetected. The majority of cases in this retrospective
study had AF associated with either cardiovascular or
systemic disease and only 1 case was diagnosed with
Table 1. The most common complete blood count and serum biochemical abnormalities detected in the 8 camelids
diagnosed with atrial fibrillation at the William R. Pritchard Veterinary Medical Teaching Hospital, University of
California, Davis over a 28-year period (1986–2014).
Abnormality Prevalence Mean  SD Reference Range
Lymphopenia 3/8 1,075  871 cells/lL 689–4,848 cells/lL
Anemia 3/8 30  8% 27–45%
Hypoalbuminemia 8/8 2.96  0.63 g/dL 4.7–7.3 g/dL
Hyperglycemia 6/8 261  106 mg/dL 71–149 mg/dL
Azotemia 5/8
Creatinine 4.6  3.5 mg/dL 1.1–3.2 mg/dL
BUN 55  46 mg/dL 9–34 mg/dL
Hyponatremia 5/8 144.9  7.5 mmol/L 148–158 mmol/L
Hypokalemia 3/8 3.83  0.79 mmol/L 3.7–6.2 mmol/L
Increased
creatine kinase
(CK)
4/8 424  456 IU/L 14–238 IU/L
Increased
gamma-glutamyl
transferase (GGT)
4/8 49  44 IU/L 6–29 IU/L
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“lone AF”. One case converted to sinus rhythm with
treatment of its oleander intoxication, but all other dis-
charged cases had persistent AF.
Based on the results of this study, it appears that
camelids might develop AF in the face of cardiac dis-
ease, other systemic diseases (urethral obstruction), as
well as with no other predisposing factors, similar to
lone AF in horses. Lone AF in camelids might be more
rarely diagnosed compared to horses because of differ-
ences in their care and management practices.
Although heart rates recorded for each individual
were variable, they generally remained within the refer-
ence range (50–110 bpm). Tachycardia was only noted
in one llama with a VSD and in this case the maxi-
mum-recorded heart rate was 127 bpm. It appears that
tachycardia is not a common complication as reported
in small animals that often develop AF secondary to
atrial dilatation. The 2 llamas noted to have atrial
enlargement did indeed have higher heart rates than the
other animals. Hence, heart rate might be more a reflec-
tion of the underlying disease causing the AF rather
than associated with the AF itself.
Clinicopathological abnormalities were associated
with the underlying disease process in the animals in
this study. Hypokalemia was present in 3/8 camelids,
which is hypothesized to be one of the risk factors for
development of AF in horses. The llama diagnosed with
lone AF had no relevant clinicopathological abnormali-
ties.
Quinidine is the drug of choice to convert AF to
sinus rhythm in horses and cattle. Quinidine sulfate was
used in an attempt to convert one llama with lone AF
to sinus rhythm, but proved unsuccessful.3 Despite lack
of conversion to sinus rhythm, the llama of that report
continued to do well clinically, as is often the case in
horses with lone atrial fibrillation that fail to convert
and are not asked to maximally exercise.3 The failure to
convert to sinus rhythm in this case might have been
caused by poor oral bioavailability of quinidine sulfate
in camelids. Intravenous quinidine gluconate might
have better success in these species, however, the phar-
macokinetics and safety require study.
Attempts at both chemical and electrical cardiover-
sion in the llama with lone AF of our report were also
unsuccessful. Pharmacokinetics of amiodarone in came-
lids have not been studied, therefore, the amiodarone
doses administered (7 mg/kg followed by 3 mg/kg the
following day) might have not been appropriate for suc-
cessful conversion. There are no reports of successful
cardioversion in camelids in the literature, and it is clear
that pharmacokinetics and safety studies of antiarrhyth-
mic drugs are warranted in these species.
Electrical cardioversion is an established technique in
addition to pharmacological cardioversion for the
restoration of sinus rhythm in humans and dogs with
AF.5 Transthoracic cardioversion has been described in
horses but is considered rarely successful.6 Transvenous
electrical cardioversion (TVEC) has been reported to be
of higher efficacy than transthoracic cardioversion in
humans and requires substantially lower energy levels.
Successful TVEC using a conventional biphasic defibril-
lator has been described in horses but has not been
reported in camelids.6–8 Transthoracic electrical car-
dioversion was attempted in the llama diagnosed with
lone AF in this study (up to 200 J) but was also unsuc-
cessful in restoring sinus rhythm.
The prognosis for cattle with AF is generally consid-
ered good if the underlying condition has been treated
and the AF has converted to normal sinus rhythm.
After conversion, an improvement in appetite and milk
production is often noted and recurrence of AF is unu-
sual unless underlying heart disease is present. The
prognosis for cattle that do not respond to quinidine
treatment is poor.2 Horses with no underlying cardiac
disease, normal heart rates, and lone AF of relative
short duration have a good prognosis for conversion
and return to previous performance level.9,10 Horses
with atrial enlargement or sustained AF for longer than
4 months before treatment have a higher recurrence
rate and higher incidence of adverse effects of quinidine
treatment. Atrial fibrillation-induced atrial contractile
dysfunction gradually improves in the weeks after car-
dioversion, but even at 7 weeks postcardioversion, sig-
nificant differences remain compared to healthy
horses.11 Attempts should be made to treat any under-
lying cardiac disease, electrolyte abnormalities, or other
underlying causes in cases where these are identified.2
Based on this report, the prognosis for camelids appears
to be primarily associated with the underlying disease
process, if present. Animals with lone AF are likely to
have a good prognosis even without conversion, pro-
vided they are not put under high exercise demands
requiring maximal cardiac output.
Cardiac output at rest in most horses with AF is
normal, however, maximal cardiac output during exer-
cise is limited because the atrial contribution to ven-
tricular filling is more important at higher heart rates;
hence, the most common clinical sign is exercise intol-
erance in high level performance horses.12 The involve-
ment of a larger proportion of horses and cattle in
high intensity practices (such as racing or eventing in
horses; peak lactation in cattle) is likely to make detec-
tion of AF more likely. This could explain the reason
for the higher incidence of AF reported in these spe-
cies. The llama that was presented for signs of exercise
intolerance in this study was diagnosed with lone AF
similar to that in horses. That llama was used for
packing at high altitude, which would be expected to
require increased cardiac output. The one additional
previously reported case of AF in a camelid also
appeared to be “lone AF”, and that llama was also
noted to do well despite failure to achieve cardiover-
sion.3
Atrial fibrillation appears to be rare in New World
Camelids and is most commonly associated with under-
lying cardiac or systemic disease. Lone AF might have
a good prognosis except for exertional or high altitude
exercise. Further studies on safety and pharmacokinet-
ics of quinidine and other antiarrhythmic medications,
as well as the use of electrical cardioversion, are war-
ranted in these species to allow for successful conver-
sion when indicated.
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